We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SVC
1276
Service Properties Trust
SVC
$989M
$53.3K ﹤0.01%
+2,073
New +$59.6K
GSAT icon
1277
Globalstar
GSAT
$10.6B
$52.1K ﹤0.01%
3,101
+158
+5% +$2.85K
ACHR icon
1278
Archer Aviation
ACHR
$4.57B
$51.4K ﹤0.01%
+14,600
New +$54.2K
PBI icon
1279
Pitney Bowes
PBI
$2.37B
$51.3K ﹤0.01%
10,098
-366
-3% -$1.75K
NAT icon
1280
Nordic American Tanker
NAT
$1.43B
$51.2K ﹤0.01%
12,875
+334
+3% +$1.34K
ETWO
1281
DELISTED
E2open Parent Holdings
ETWO
$49.8K ﹤0.01%
11,086
+613
+6% +$2.76K
BDN
1282
Brandywine Realty Trust
BDN
$534M
$48.6K ﹤0.01%
10,854
+557
+5% +$2.54K
LESL icon
1283
Leslie's
LESL
$4.99M
$48.5K ﹤0.01%
578
+38
+7% +$3.7K
CIFR icon
1284
Cipher Digital
CIFR
$6.96B
$45.2K ﹤0.01%
+10,898
New +$45.1K
UNIT
1285
Uniti Group
UNIT
$2.46B
$44.6K ﹤0.01%
15,291
+862
+6% +$3.61K
EU
1286
enCore Energy
EU
$270M
$43.5K ﹤0.01%
+11,037
New +$48.8K
DHC
1287
Diversified Healthcare Trust
DHC
$1.9B
$41.6K ﹤0.01%
13,627
-412
-3% -$1.04K
CHPT icon
1288
ChargePoint
CHPT
$151M
$36.4K ﹤0.01%
1,207
-781
-39% -$25.4K
BLND icon
1289
Blend Labs
BLND
$364M
$34.6K ﹤0.01%
+14,679
New +$38.9K
LYG icon
1290
Lloyds Banking Group
LYG
$85.7B
$33.9K ﹤0.01%
12,430
+2,267
+22% +$6.08K
LAB icon
1291
Standard BioTools
LAB
$256M
$33.9K ﹤0.01%
+19,143
New +$46.8K
CNDT icon
1292
Conduent
CNDT
$271M
$33.5K ﹤0.01%
10,287
NUVB icon
1293
Nuvation Bio
NUVB
$2.45B
$33.1K ﹤0.01%
+11,351
New +$34.6K
LAZR
1294
DELISTED
Luminar Technologies
LAZR
$31.4K ﹤0.01%
1,405
+230
+20% +$5.45K
CCO icon
1295
Clear Channel Outdoor Holdings
CCO
$1.22B
$31.2K ﹤0.01%
22,143
NXDR
1296
Nextdoor Holdings
NXDR
$897M
$30.6K ﹤0.01%
+11,021
New +$25.5K
SMRT icon
1297
SmartRent
SMRT
$261M
$29.3K ﹤0.01%
12,256
+998
+9% +$2.45K
CLNE icon
1298
Clean Energy Fuels
CLNE
$353M
$28.9K ﹤0.01%
10,833
+489
+5% +$1.26K
ESPR
1299
DELISTED
Esperion Therapeutics
ESPR
$27.6K ﹤0.01%
+12,445
New +$29.3K
OPK icon
1300
Opko Health
OPK
$1.12B
$26.1K ﹤0.01%
20,842
-2,800
-12% -$3.63K

Similar funds

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.